A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours

Maja J.A. de Jonge, Vincent A. de Weger, Mark A. Dickson, Marlies H.G. Langenberg, Axel Le Cesne, Andrew J. Wagner, Karl Hsu, Wei Zheng, Sandrine Macé, Gilles Tuffal,

European Journal of Cancer · 2017 · 126 citations · 16 references

Concepts

References

16